Valuation: OneSource Specialty Pharma Limited

Market Cap 187B 1.99B 1.79B 1.63B 1.49B 2.81B 2.9B 19.68B 7.85B 99.89B 7.48B 7.32B 315B P/E 2027 *
36.2x
P/E 2028 * 21x
Enterprise Value 196B 2.09B 1.87B 1.71B 1.56B 2.94B 3.03B 20.61B 8.22B 105B 7.83B 7.66B 330B EV / Sales 2027 *
8.28x
EV / Sales 2028 * 5.49x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day+2.05%
1 week+4.77%
Current month+4.45%
1 month+10.45%
3 months+3.63%
6 months-11.04%
Current year-9.83%
1 week 1,535.5
Extreme 1535.5
1,644
1 month 1,320.6
Extreme 1320.6
1,644
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,917.8
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Chairman 65 22/09/2025
Director/Board Member 55 27/02/2025
Director/Board Member 66 23/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
+2.05%+4.77%-8.86% - 1.95B
-4.83%+3.51%+55.00%+63.79% 66.7B
+0.02%+1.07%+11.72%+75.63% 56.88B
-1.34%+2.98%+25.08%+100.18% 56.53B
+5.09%+9.89%+27.19%+105.85% 46.49B
+2.62%+1.68%+29.16%+35.86% 44.8B
+8.24%+0.51%+215.16%+794.74% 41.59B
-1.86%+10.13%+28.14%+55.48% 35.35B
-2.97%-9.84%+90.91%+73.49% 33.29B
+5.19%+1.62%-39.69%+368.87% 25.1B
Average +1.22%+2.62%+43.38%+185.99% 40.87B
Weighted average by Cap. +0.66%+3.07%+49.62%+165.88%

Financials

2027 *2028 *
Net sales 23.69B 252M 226M 207M 189M 355M 366M 2.49B 993M 12.64B 946M 926M 39.9B 34.34B 365M 328M 299M 273M 515M 531M 3.61B 1.44B 18.32B 1.37B 1.34B 57.84B
Net income 4.6B 48.96M 43.91M 40.13M 36.63M 69.02M 71.2M 484M 193M 2.46B 184M 180M 7.75B 8.99B 95.67M 85.81M 78.42M 71.59M 135M 139M 945M 377M 4.8B 359M 351M 15.15B
Net Debt 8.86B 94.21M 84.5M 77.22M 70.49M 133M 137M 931M 371M 4.73B 354M 346M 14.92B 1.16B 12.38M 11.11M 10.15M 9.27M 17.46M 18.01M 122M 48.78M 621M 46.48M 45.48M 1.96B
Projected Income Statement - Annual - OneSource Specialty Pharma Limited
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Employees
1,674
Date Price Change Volume
08/11/26 INR 1,632.60 +2.05% 61,995
06/11/26 INR 1,599.80 +1.13% 276,774
05/11/26 INR 1,581.90 -0.11% 654,875
04/11/26 INR 1,583.60 +0.95% 481,453
03/11/26 INR 1,568.70 +0.67% 318,991
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - OneSource Specialty Pharma Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,599.80INR
Average target price
2,078.25INR
Spread / Average Target
+29.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OneSource Specialty Pharma Limited
  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock